Literature DB >> 27594983

A patient with MEN1 typical features and MEN2-like features.

Diala El-Maouche1, James Welch2, Sunita K Agarwal2, Lee S Weinstein2, William F Simonds2, Stephen J Marx2.   

Abstract

Multiple endocrine neoplasia (MEN) type 1 (MEN1) and 2 (MEN2) rarely co-exist in one case. Here we report a patient with features of both syndromes. The patient presented with typical MEN1 features plus pheochromocytoma and thickened corneal nerves. She had a germline 1132delG frameshift mutation in MEN1, no mutation in CDKN1B (p27) and no RET mutation, but had both RET polymorphisms Gly691Ser and Arg982Cys. This is the first case report of a combination of typical clinical findings of MEN1 harboring a germline MEN1 mutation and the MEN2-like phenotype with negative full RET gene analysis of pathogenic variants. Possible explanations include a previously unrecognized phenotype-genotype association or the influence of potential phenotypic modifying RET variants. Furthermore, the combination observed in this patient may point to a single molecular pathway, and supports the possibility of as yet unrecognized connections between the molecular pathways for MEN1/menin protein and MEN2/RET protein.

Entities:  

Keywords:  1132delG; G691S; MEN1; MEN2; MEN4; MENX; R982C; multiple endocrine neoplasias

Year:  2016        PMID: 27594983      PMCID: PMC5008851          DOI: 10.2217/ije-2015-0008

Source DB:  PubMed          Journal:  Int J Endocr Oncol        ISSN: 2045-0869


  31 in total

1.  Screening for MEN1 mutations in patients with atypical endocrine neoplasia.

Authors:  A P Dackiw; G J Cote; J B Fleming; P N Schultz; P Stanford; R Vassilopoulou-Sellin; D B Evans; R F Gagel; J E Lee
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

3.  Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family.

Authors:  Sandra Mastroianno; Massimo Torlontano; Alfredo Scillitani; Leonardo D'Aloiso; Antonella Verrienti; Nazario Bonfitto; Antonio De Bonis; Leonardo D'Agruma; Lucia Anna Muscarella; Vito Guarnieri; Franca Dicembrino; Marianna Maranghi; Cosimo Durante; Sebastiano Filetti
Journal:  Endocrine       Date:  2011-06-17       Impact factor: 3.633

Review 4.  Molecular genetics of multiple endocrine neoplasia types 1 and 2.

Authors:  Stephen J Marx
Journal:  Nat Rev Cancer       Date:  2005-05       Impact factor: 60.716

5.  Typical ocular findings in a patient with multiple endocrine neoplasia type 2b syndrome.

Authors:  N Eter; D Klingmüller; W Höppner; M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-06       Impact factor: 3.117

6.  Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism.

Authors:  Maria Grazia Borrello; Antonella Aiello; Bernard Peissel; Maria Grazia Rizzetti; Piera Mondellini; Debora Degl'Innocenti; Veronica Catalano; Morena Gobbo; Paola Collini; Italia Bongarzone; Marco A Pierotti; Angela Greco; Ettore Seregni
Journal:  Endocr Relat Cancer       Date:  2011-07-25       Impact factor: 5.678

7.  Adrenal involvement in multiple endocrine neoplasia type 1.

Authors:  Peter Langer; Kenko Cupisti; Detlef K Bartsch; Christoph Nies; Peter E Goretzki; Matthias Rothmund; Hans D Röher
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

8.  Multiple orbital neurofibromas, painful peripheral nerve tumors, distinctive face and marfanoid habitus: a new syndrome.

Authors:  D Babovic-Vuksanovic; Ludwine Messiaen; Christoph Nagel; Hilde Brems; Bernd Scheithauer; Ellen Denayer; Rong Mao; Raf Sciot; Karen M Janowski; Martin U Schuhmann; Kathleen Claes; Eline Beert; James A Garrity; Robert J Spinner; Anat Stemmer-Rachamimov; Ralitza Gavrilova; Frank Van Calenbergh; Victor Mautner; Eric Legius
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

9.  Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.

Authors:  Zoran Erlic; Michael M Hoffmann; Maren Sullivan; Gerlind Franke; Mariola Peczkowska; Igor Harsch; Matthias Schott; Helmut E Gabbert; Matti Valimäki; Simon F Preuss; Kornelia Hasse-Lazar; Dariusz Waligorski; Mercedes Robledo; Andrzej Januszewicz; Charis Eng; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

10.  Histologic study of the ocular lesions in multiple endocrine neoplasia syndrome type IIb.

Authors:  B Spector; G K Klintworth; S A Wells
Journal:  Am J Ophthalmol       Date:  1981-02       Impact factor: 5.258

View more
  3 in total

Review 1.  MEN4 and CDKN1B mutations: the latest of the MEN syndromes.

Authors:  Rami Alrezk; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2017-08-19       Impact factor: 5.678

2.  Multiple Uterine Leiomyomas in Multiple Endocrine Neoplasia Type 1 with a Novel MEN1 Gene Mutation.

Authors:  Raiz Ahmad Misgar; Danendra Sahu; Sameer Purra; Arshad Iqbal Wani; Mir Iftikhar Bashir
Journal:  J Hum Reprod Sci       Date:  2020-04-07

3.  18F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma.

Authors:  Aisha A Tepede; James Welch; Maya Lee; Adel Mandl; Sunita K Agarwal; Naris Nilubol; Dhaval Patel; Craig Cochran; William F Simonds; Lee S Weinstein; Abhishek Jha; Corina Millo; Karel Pacak; Jenny E Blau
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.